Uqba Khan is an Oncology physician affiliated with Weill Cornell Medicine. OpenAlex indexes 79 publications with 1,487 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
501 6th St
Brooklyn, NY 11215
Telephone
646-962-6200Provider last certified this registry record 6 Feb 2025.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BeOne Medicines USA, Inc.Program year202518 payments$27,565openpaymentsdata.cms.gov ↗
- BeiGene USA, Inc.Program year20257 payments
- AVYXA PHARMA, LLCProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.4%Serotonin-3 Receptor Antagonist27.8%Ondansetron Hcl100%Part D≥25 patientsOpioid Agonist9.6%Loperamide100%Part D≥11 patientsNervous system
32.6%Phenothiazine20.9%Prochlorperazine Maleate100%Part D≥22 patientsOpioid Agonist11.8%Oxycodone Hcl100%Part D≥12 patientsSensory organs
12.8%Corticosteroid12.8%Dexamethasone100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases
Annals of Surgical Oncology
2025 - Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms
Annals of Surgical Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jedd Wolchok, MD
Weill Cornell Medicine
Richard Devereux, MD
Weill Cornell Medicine
Ronald Crystal, MD
Weill Cornell Medicine
Robert Harrington, MD
Weill Cornell Medicine
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”